Wells Fargo & Company Macrogenics Inc Transaction History

Wells Fargo & Company

$407 Billion
Q2 2024

A detailed history of Wells Fargo & Company transactions in Macrogenics Inc stock. As of the latest transaction made, Wells Fargo & Company holds 20,976 shares of MGNX stock, worth $75,303. This represents 0.0% of its overall portfolio holdings.

Number of Shares

20,976

Previous 20,708 1.29%

Holding current value

$75,303

Previous $304,000 70.72%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$3.31 - $18.51 $887 - $4,960	268 Added 1.29%	20,976 $89,000
Q1 2024 May 10, 2024	BUY	$9.77 - $21.47 $26,007 - $57,153	2,662 Added 14.75%	20,708 $304,000
Q4 2023 Feb 09, 2024	BUY	$4.48 - $10.11 $15,989 - $36,082	3,569 Added 24.65%	18,046 $173,000
Q3 2023 Nov 13, 2023	SELL	$4.48 - $6.19 $42,600 - $58,860	-9,509 Reduced 39.64%	14,477 $67,000
Q2 2023 Aug 15, 2023	BUY	$4.62 - $7.54 $60,665 - $99,007	13,131 Added 120.97%	23,986 $128,000
Q1 2023 May 12, 2023	BUY	$4.82 - $7.24 $51,434 - $77,258	10,671 Added 5799.46%	10,855 $77,000
Q4 2022 Feb 13, 2023	SELL	$3.34 - $6.98 $11,462 - $23,955	-3,432 Reduced 94.91%	184 $1,000
Q3 2022 Nov 14, 2022	SELL	$3.01 - $5.22 $1,866 - $3,236	-620 Reduced 14.64%	3,616 $12,000
Q2 2022 Aug 12, 2022	SELL	$2.25 - $9.99 $74,990 - $332,956	-33,329 Reduced 88.72%	4,236 $12,000
Q1 2022 May 16, 2022	SELL	$8.12 - $16.9 $159,103 - $331,138	-19,594 Reduced 34.28%	37,565 $332,000
Q4 2021 Feb 14, 2022	SELL	$15.91 - $21.88 $485,509 - $667,690	-30,516 Reduced 34.81%	57,159 $917,000
Q3 2021 Nov 15, 2021	SELL	$19.74 - $28.7 $327,348 - $475,932	-16,583 Reduced 15.91%	87,675 $1.84 Million
Q2 2021 Aug 16, 2021	SELL	$20.49 - $35.63 $767,903 - $1.34 Million	-37,477 Reduced 26.44%	104,258 $2.8 Million
Q1 2021 May 13, 2021	BUY	$18.99 - $33.2 $170,758 - $298,534	8,992 Added 6.77%	141,735 $4.52 Million
Q4 2020 Feb 09, 2021	BUY	$19.41 - $26.0 $1.49 Million - $2 Million	76,945 Added 137.9%	132,743 $3.03 Million
Q3 2020 Nov 05, 2020	BUY	$24.69 - $31.6 $97,500 - $124,788	3,949 Added 7.62%	55,798 $1.41 Million
Q2 2020 Aug 13, 2020	BUY	$5.2 - $29.12 $37,700 - $211,120	7,250 Added 16.26%	51,849 $1.45 Million
Q1 2020 May 14, 2020	BUY	$4.28 - $12.11 $190,883 - $540,093	44,599 New	44,599 $260,000

Others Institutions Holding MGNX

# of Institutions

155

Shares Held

60.6M

Call Options Held

218K

Put Options Held

259K

View Full List

About MACROGENICS INC

Ticker MGNX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 61,458,800
Market Cap $221M
Description
MacroGenics, Inc., a biopharmaceutical company, develops and commercializes antibody-based therapeutics to treat cancer in the United States. Its approved product is MARGENZA (margetuximab-cmkb), a human epidermal growth factor receptor 2 (HER2) receptor antagonist indicated, in combination with chemotherapy, for the treatment of adult patients ...

More about MGNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Macrogenics Inc Transaction History